Revisiting the business case in 'the business case for quality'
The author is writing to comment on a featured article in the October 2009 issue of hfm, "The Business Case for Quality" (Richard Boehier, MD, Daniel Hardesty, MD, Eva Gonzales, and Karen Kasnetz). Two flaws in the business case as presented in the article require attention. The first is t...
Saved in:
Published in | Healthcare Financial Management Vol. 64; no. 1; pp. 24 - 25 |
---|---|
Main Author | |
Format | Journal Article Trade Publication Article |
Language | English |
Published |
Westchester
Healthcare Financial Management Association
01.01.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The author is writing to comment on a featured article in the October 2009 issue of hfm, "The Business Case for Quality" (Richard Boehier, MD, Daniel Hardesty, MD, Eva Gonzales, and Karen Kasnetz). Two flaws in the business case as presented in the article require attention. The first is the assertion that the financial benefit of the quality improvement initiative is based on average cost. The second flaw is that the potential revenue impact was neither considered nor measured as part of the quality improvement initiative. The team should be complimented. This was a great clinical initiative (the team saved 62 lives!). But the team misstated the business case. |
---|---|
ISSN: | 0735-0732 0735-0732 |